136 related articles for article (PubMed ID: 37774076)
1. Mismatch Repair Protein Deficiency Does Not Affect Disease Free Survival in Type I Endometrial Carcinoma.
Angelina YA; Tjokroprawiro BA; Sandhika W
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3229-3234. PubMed ID: 37774076
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Clinicopathologic Analysis for Mismatch Repair Protein Expression in Unselected Endometrial Carcinoma Patients With an Emphasis on the Role of MLH1 Deficiency.
Huang SW; Lin H; Huang CC; Ou YC; Fu HC; Tsai CC; Changchien CC; Wu CH
Int J Gynecol Pathol; 2022 Jul; 41(4):407-416. PubMed ID: 34347667
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tissue Mismatch Repair Protein Deficiency between Early- and Advanced-Stage Endometrial Cancer.
Chaowiwatkun K; Trongwongsa T; Rodpenpear N; Nutthachote P
Asian Pac J Cancer Prev; 2023 Jan; 24(1):345-351. PubMed ID: 36708586
[TBL] [Abstract][Full Text] [Related]
4. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
[No Abstract] [Full Text] [Related]
5. Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy.
Russo AL; Lee LJ; Wo JY; Niemierko A; Park D; Alban G; King M; Philp L; Growdon WB; Oliva E; Spriggs DR; Yeku OO
Am J Clin Oncol; 2022 Jan; 45(1):36-39. PubMed ID: 34817442
[TBL] [Abstract][Full Text] [Related]
6. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
[No Abstract] [Full Text] [Related]
7. Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China.
Zhao G; Xiang G; Hu X; Qiao Y; Ma S; Tian Y; Gao X; Liu F; Li X; Shi G
Eur J Cancer Prev; 2023 Jul; 32(4):337-347. PubMed ID: 36942852
[TBL] [Abstract][Full Text] [Related]
8. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study.
Pina A; Wolber R; McAlpine JN; Gilks B; Kwon JS
Int J Gynecol Cancer; 2018 Oct; 28(8):1624-1630. PubMed ID: 30095707
[TBL] [Abstract][Full Text] [Related]
9. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
10. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
Zhang YH; Wu HW; Wang J; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653
[No Abstract] [Full Text] [Related]
12. [Correlation of NTRK genetic fusions with mismatch repair protein deletion in patients with colorectal cancer].
Pu XH; Gao FP; Wu HY; Fu Y; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):103-107. PubMed ID: 35152627
[No Abstract] [Full Text] [Related]
13. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
Lee PJ; McNulty S; Duncavage EJ; Heusel JW; Hagemann IS
Int J Gynecol Pathol; 2018 Nov; 37(6):581-589. PubMed ID: 29084048
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinoma and Tumor-associated Immune Cells: Differences Between MLH1 Methylated and Nonmethylated Subgroups.
Kir G; Olgun ZC; Soylemez T; Aydin A; Demircan B; Kaya IA; McCluggage WG
Int J Gynecol Pathol; 2021 Nov; 40(6):575-586. PubMed ID: 33332859
[TBL] [Abstract][Full Text] [Related]
15. The Correlation of Histopathologic Parameters With Mismatch Repair Protein-deficient Subgroups and MLH1 Methylation in Endometrial Carcinomas.
Soylemez T; Kir G; Olgun ZC; Dur SR; Tosun MI; Ankarali H; Demircan B; Kaya IA; Karateke A
Int J Gynecol Pathol; 2022 Sep; 41(5):484-495. PubMed ID: 34723847
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and survival characteristic of mismatch repair status in ovarian clear cell carcinoma.
Zhu J; Ke G; Bi R; Wu X
J Surg Oncol; 2020 Sep; 122(3):538-546. PubMed ID: 32396667
[TBL] [Abstract][Full Text] [Related]
17. Lynch Syndrome in Thai Endometrial Cancer Patients.
Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P
Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Deficient Mismatch Repair in Stage II-IVa Nasopharyngeal Carcinoma in the Era of IMRT.
Chen FM; Zhang YX; Li XF; Gao JF; Ma H; Wang XL; Li Y; Li C; Zhang YN; Zhang YT; Kan HX; Li H; Zhang SG; Hao FR; Wang MC
Sci Rep; 2020 Jun; 10(1):9690. PubMed ID: 32546739
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
